Resistance Training for Patients With Hypermobility Spectrum Disorders and Shoulder Symptoms: a Feasibility Study

NCT03547570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-04-30

No results posted yet for this study

Summary

Hypermobility Spectrum Disorders (HSD) is a recent diagnosis that covers joint hypermobility with one or more secondary symptomatic musculoskeletal manifestations. Current clinical management of this population with shoulder symptoms is a non-standardized combination of physiotherapy modalities including exercise prescription. There is evidence suggesting that progressive heavy resistance training increases muscle strength and tendon stiffness, which may be valuable for treatment of this population.

The aim of this study is to evaluate the feasibility of progressive heavy shoulder resistance training (PHSRT) for adults with HSD and shoulder symptoms.

Conditions

  • Hypermobility Syndrome Shoulder
  • Shoulder Pain Chronic

Interventions

OTHER

Progressive heavy shoulder resistance training

The training programme includes five exercises identified in literature to target scapular and rotator cuff muscles.

Sponsors & Collaborators

  • Esbjerg Municipality

    collaborator OTHER_GOV
  • Region of Southern Denmark

    collaborator OTHER
  • The Danish Rheumatism Association

    collaborator OTHER
  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Behnam Liaghat, MSc · University of Southern Denmark

  • Birgit Juul-Kristensen, PhD · University of Southern Denmark

  • Søren T Skou, PhD · University of Southern Denmark, Næstved-Slagelse-Ringsted Hospitals

  • Karen Søgaard, PhD · University of Southern Denmark

  • Jens Søndergaard, MD, PhD · University of Southern Denmark

  • Uffe Jørgensen, MD · Odense University Hospital, University of Southern Denmark

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-04
Primary Completion
2018-11-06
Completion
2018-11-06

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547570 on ClinicalTrials.gov